Insilico Medicine Secures Spot in MSCI Global Small Cap Indexes Effective 31 Aug 2026

Bulletin Express08-17 08:23

Insilico Medicine Cayman TopCo (Insilico Medicine) announced it will be added to the MSCI Global Small Cap Indexes at the close of trading on 31 Aug 2026. The index series tracks small-capitalisation companies across developed and emerging markets, broadening visibility among global institutional investors.

The biotechnology group has already been admitted to multiple benchmark indices since its Hong Kong listing, including: • CSI Hong Kong Connect Innovative Drug Index • CSI Hong Kong Brand Name Drug Index • CSI HK Connect Health Care Composite Index • Hang Seng Composite Index • Hang Seng Healthcare Index • Hang Seng Biotechnology Index • FTSE Global Small Cap, All-Cap and Total-Cap Indexes

The Board stated that the forthcoming MSCI inclusion underscores market recognition of Insilico Medicine’s competitive strengths, scalable business model and commercial potential. Management expects the development to increase research coverage, attract passive fund inflows, diversify the shareholder base and enhance trading liquidity.

The company reiterated that forward-looking statements remain subject to uncertainties and that the financial data referenced in the announcement have not been audited or reviewed. Shareholders and prospective investors are advised to exercise caution when dealing in the company’s shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1114024051?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-17 08:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1114024051","market":"us","top_or_hot":-1,"title":"Insilico Medicine Secures Spot in MSCI Global Small Cap Indexes Effective 31 Aug 2026","media":"Bulletin Express","content":"<p>Insilico Medicine Cayman TopCo (Insilico Medicine) announced it will be added to the MSCI Global Small Cap Indexes at the close of trading on 31 Aug 2026. The index series tracks small-capitalisation companies across developed and emerging markets, broadening visibility among global institutional investors.</p>\n<p>The biotechnology group has already been admitted to multiple benchmark indices since its Hong Kong listing, including:\n• CSI Hong Kong Connect Innovative Drug Index  \n• CSI Hong Kong Brand Name Drug Index  \n• CSI HK Connect Health Care Composite Index  \n• Hang Seng Composite Index  \n• Hang Seng Healthcare Index  \n• Hang Seng Biotechnology Index  \n• FTSE Global Small Cap, All-Cap and Total-Cap Indexes</p>\n<p>The Board stated that the forthcoming MSCI inclusion underscores market recognition of Insilico Medicine’s competitive strengths, scalable business model and commercial potential. Management expects the development to increase research coverage, attract passive fund inflows, diversify the shareholder base and enhance trading liquidity.</p>\n<p>The company reiterated that forward-looking statements remain subject to uncertainties and that the financial data referenced in the announcement have not been audited or reviewed. Shareholders and prospective investors are advised to exercise caution when dealing in the company’s shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Insilico Medicine Secures Spot in MSCI Global Small Cap Indexes Effective 31 Aug 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInsilico Medicine Secures Spot in MSCI Global Small Cap Indexes Effective 31 Aug 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-17 08:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Insilico Medicine Cayman TopCo (Insilico Medicine) announced it will be added to the MSCI Global Small Cap Indexes at the close of trading on 31 Aug 2026. The index series tracks small-capitalisation companies across developed and emerging markets, broadening visibility among global institutional investors.</p>\n<p>The biotechnology group has already been admitted to multiple benchmark indices since its Hong Kong listing, including:\n• CSI Hong Kong Connect Innovative Drug Index  \n• CSI Hong Kong Brand Name Drug Index  \n• CSI HK Connect Health Care Composite Index  \n• Hang Seng Composite Index  \n• Hang Seng Healthcare Index  \n• Hang Seng Biotechnology Index  \n• FTSE Global Small Cap, All-Cap and Total-Cap Indexes</p>\n<p>The Board stated that the forthcoming MSCI inclusion underscores market recognition of Insilico Medicine’s competitive strengths, scalable business model and commercial potential. Management expects the development to increase research coverage, attract passive fund inflows, diversify the shareholder base and enhance trading liquidity.</p>\n<p>The company reiterated that forward-looking statements remain subject to uncertainties and that the financial data referenced in the announcement have not been audited or reviewed. Shareholders and prospective investors are advised to exercise caution when dealing in the company’s shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1114024051","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1114024051","pubTimestamp":1786926199,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Insilico Medicine Cayman TopCo (Insilico Medicine) announced it will be added to the MSCI Global Small Cap Indexes at the close of trading on 31 Aug 2026. The index series tracks small-capitalisation...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"Insilico Medicine 获得 MSCI 全球小型股指数席位，自 2026 年 8 月 31 日起生效","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"Insilico Medicine Cayman TopCo (Insilico Medicine) announced it will be added to the MSCI Global Small Cap Indexes at the close of trading on 31 Aug 2026. The index series tracks small-capitalisation companies across developed and emerging markets, broadening visibility among global institutional investors.\nThe biotechnology group has already been admitted to multiple benchmark indices since its Hong Kong listing, including:\n• CSI Hong Kong Connect Innovative Drug Index  \n• CSI Hong Kong Brand Name Drug Index  \n• CSI HK Connect Health Care Composite Index  \n• Hang Seng Composite Index  \n• Hang Seng Healthcare Index  \n• Hang Seng Biotechnology Index  \n• FTSE Global Small Cap, All-Cap and Total-Cap Indexes\nThe Board stated that the forthcoming MSCI inclusion underscores market recognition of Insilico Medicine’s competitive strengths, scalable business model and commercial potential. Management expects the development to increase research coverage, attract passive fund inflows, diversify the shareholder base and enhance trading liquidity.\nThe company reiterated that forward-looking statements remain subject to uncertainties and that the financial data referenced in the announcement have not been audited or reviewed. Shareholders and prospective investors are advised to exercise caution when dealing in the company’s shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1114024051","isCrawlerRequest":true}